Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Europe

Improving Patient Care by Removing Barriers to Drug Accessibility

Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and...

Impetus Digital

Webcast

Monitoring the impact of COVID-19 on the market access landscape

Research Partnership

Case study

Using qualitative conjoint to assess willingness-to-pay

Research Partnership

Article: Pricing a coronavirus vaccine

Using findings from Research Partnership's recent COVID-19 impact study, Market Access Directors Rachel Howard and Brett Gardiner and Consultant Suzan Serip explore the challenges of pricing a coronavirus vaccine. Read...

Research Partnership

- PMLiVE

AMICULUM® launches new specialist agency: AMICULUM Access

AMICULUM Access is a full-service market access agency bringing together existing in-house market access expertise from across AMICULUM’s agencies to provide a consolidated service to both new and existing clients.

AMICULUM

- PMLiVE

Four Comms restructures, reveals 2019 revenue growth and acquisition plan

Four Communications has undergone a restructure, with 17 practices reorganised into seven business units - as the firm reveals that revenue grew eight per cent in 2019. It is also...

Four Health

- PMLiVE

OPEN Health expands global footprint with Pharmerit International integration

Global health comms and market access group now has presence in six countries

- PMLiVE

Von der Leyen elected new European Commission president

Pledges green deal and universal healthcare for 500m citizens

- PMLiVE

Europe urged to adapt faster to gene therapy challenges

Resistance to high prices, even with novel payment models

- PMLiVE

Ursula von der Leyen nominated for EU President role

Plans could be blocked by MEPs

A new EU in the making, what lies ahead for pharma?

Big decisions on Europe's leaders and strategy await

- PMLiVE

A first for Bluebird and Europe as gene therapy Zynteglo approved

Will product be priced over $1m?

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links